This is a match-making section for IMPRESS-U.
right ventricular fialure; pulmonary hypertension; heart failure; cardiovascular disease
My expertise: rat models of right ventricular failure caused by pulmonary hypertension (monocrotaline, pulmonary artery banding, left heart disease - post-myocardial infarction); human explanted hearts (end-stage heart failure and healthy hearts unused for transplantation) and isolated cells from these hearts. Expertise we are looking for: anything that will contribute to the project
We and others have shown that right ventricular (RV) hypoxia is a universal finding in various forms of RV failure (RVF) and precedes the development of over failure. Therefore we hypothesize that prevention of RV hypoxia could prevent or at least delay the development of RVF. Thus our goal is to verify if hypoxia-combating strategies are able to prevent the development of RVF in two rat models of RVF: pulmonary artery banding (RV overload, mimicking PAH, PH-pulmonary disease and thromboembolic PH) and post-myocardial infarction (mimicking PH-LHD) and study its mechanisms. Specifically, the project will address the following research questions. Do hypoxia and impaired energetics drive the development of RVF? Does hypoxia impair red blood cell metabolism that contributes to RVF pathology? Can alleviation of hypoxia by ITPP improve RV function and survival? Is RV fibrosis the eventual mediator of hypoxia in RV pathology? Are there sex-related differences in response to RV overload and hypoxia? Are there sex-related differences in ITPP effectiveness? Can we get a glimpse of these pathologies in humans?
Submitted on 2024-11-24 15:44:02
« Return to the partner search tool